Discontinuation of Adalimumab After Attaining Disease Activity Score 28-Erythrocyte Sedimentation Rate Remission in Patients With Rheumatoid Arthritis (HONOR Study): An Observational Study
Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar4315
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC